Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-07 10:01 am Sale | 2025-02-28 | 13G | Allogene Therapeutics, Inc. ALLO | FMR LLC | 10,225,851 4.900% | -13,546,144 (-56.98%) | Filing History |
| 2025-02-14 09:02 am Purchase | 2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Lynx1 Capital Management LP | 10,874,723 5.200% | 10,874,723 (New Position) | Filing History |
| 2025-02-13 4:31 pm Purchase | 2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Belldegrun Arie | 12,393,567 5.800% | 2,497,664 (+25.24%) | Filing History |
| 2025-02-13 4:29 pm Purchase | 2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Chang David D | 10,905,003 5.100% | 940,656 (+9.44%) | Filing History |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | FMR LLC | 23,771,995 11.300% | -1,469,504 (-5.82%) | Filing History |
| 2024-11-12 1:26 pm Unchanged | 2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO | The Vanguard Group | 8,327,699 3.980% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO | BlackRock Inc. BLK | 17,772,745 8.500% | 0 (Unchanged) | Filing History |
| 2024-11-04 10:57 am Sale | 2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO | The Vanguard Group | 8,327,699 3.980% | -703,126 (-7.79%) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Allogene Therapeutics, Inc. ALLO | BlackRock Inc. BLK | 17,772,745 8.500% | 7,770,941 (+77.70%) | Filing History |
| 2024-02-14 4:36 pm Purchase | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Belldegrun Arie | 9,895,903 5.800% | 1,037,042 (+11.71%) | Filing History |
| 2024-02-14 4:32 pm Purchase | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Chang David D | 9,964,347 5.800% | 1,536,715 (+18.23%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Allogene Therapeutics, Inc. ALLO | The Vanguard Group | 9,030,825 5.370% | 1,765,604 (+24.30%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Allogene Therapeutics, Inc. ALLO | FMR LLC | 25,241,499 14.999% | 323,544 (+1.30%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | BlackRock Inc. BLK | 10,001,804 5.900% | 1,115,232 (+12.55%) | Filing History |
| 2024-01-23 10:02 am Sale | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | STATE STREET CORP STT | 2,427,284 1.440% | -6,739,124 (-73.52%) | Filing History |
| 2023-10-25 5:29 pm Unchanged | 2023-08-02 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 13.140% | 0 (Unchanged) | Filing History |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | Allogene Therapeutics, Inc. ALLO | FMR LLC | 24,917,955 17.085% | 24,917,955 (New Position) | Filing History |
| 2023-02-13 4:33 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Chang David D | 8,427,632 5.700% | 8,427,632 (New Position) | Filing History |
| 2023-02-13 4:31 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Belldegrun Arie | 8,858,861 6.100% | 1,655,613 (+22.98%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Allogene Therapeutics, Inc. ALLO | The Vanguard Group | 7,265,221 5.040% | 7,265,221 (New Position) | Filing History |